Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma


Cetin B., Afsar B., Deger S. M. , IŞIK GÖNÜL İ. , Gumusay O., ÖZET A. , ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, ss.1081-1087, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 46 Konu: 6
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s11255-013-0613-x
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Sayfa Sayıları: ss.1081-1087

Özet

There are no robust data on hemoglobin (Hb), lactate dehydrogenase (LDH), and calcium variability for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy. We aim to evaluate prognostic implications of Hb, LDH, and calcium variability and establish a novel risk stratification model in RCC patients receiving targeted therapies.